GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

Jan. 29, Marist University celebrated their official designation change, along with a new logo and commercial. Here's what to ...

Walmart has already updated its social media accounts to reflect the new logo and wordmark, leading to critical and confused reactions from users. One shared the “before and after” images of ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,359. ...

The internet, especially X (formerly Twitter), is awash with memes and jokes about the new logo A user commented, "Some consulting firm fleeced them for $500M for this." Some consulting firm ...

Instead, Walmart gave its logo a makeover fit for modern times ... but the colors appear brighter. The names of the new shades are True Blue and Spark Yellow. What are people saying about ...

Youngkin had halted assembly plans to build a new building at the Main Street property. He argued that the faltering commercial office market after the COVID-19 pandemic offered a better, cheaper ...

A total of P4.2 billion was appropriated for the new Senate building in the 2025 national budget, bringing the total allocation to the structure to P23.5 billion since 2018. In Mav Gonzales’ Wednesday ...

Walmart announced on Monday that it had unveiled a new logo, part of "a comprehensive brand refresh." The U.S.-based retailer boasted in a news release that the new look — its first change ...

Walmart announced Monday, Jan. 13, it was excited to introduce a "brand refresh," updating its logo. "This updated brand ... Expect to see the new branding arrive at stores around the country ...

GSK has planned five new product approvals in 2025 and the forefront of these is Blenrep, an off-the-shelf ADC1 for multiple myeloma. Next in line is depemokimab, a long-acting IL-56 for ...